Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression
Authors
Keywords
-
Journal
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-02-19
DOI
10.1002/hup.2836
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intravenous arketamine for treatment-resistant depression: open-label pilot study
- (2020) Gustavo C. Leal et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- The identification, assessment and management of difficult-to-treat depression: An international consensus statement
- (2020) R.H. McAllister-Williams et al. JOURNAL OF AFFECTIVE DISORDERS
- How can we improve antidepressant adherence in the management of depression? A targeted review and 10 clinical recommendations
- (2020) Marco Solmi et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Ketamine and Esketamine augmentation for suicidal ideation: A randomized, double-blinded clinical trial
- (2020) Flávia Vieira et al. GENERAL HOSPITAL PSYCHIATRY
- General Predictors and Moderators of Depression Remission: A VAST-D Report
- (2019) Sidney Zisook et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3
- (2019) Rachel Ochs-Ross et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Esketamine: a glimmer of hope in treatment-resistant depression
- (2019) Upinder Kaur et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study
- (2019) Fernanda S. Correia-Melo et al. JOURNAL OF AFFECTIVE DISORDERS
- Esketamine is approved in Europe for treating resistant major depressive disorder
- (2019) Elisabeth Mahase BMJ-British Medical Journal
- Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
- (2018) Carola Rong et al. International Journal of Environmental Research and Public Health
- Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review
- (2018) Yena Lee et al. JOURNAL OF AFFECTIVE DISORDERS
- Difficult-to-treat depression: A clinical and research roadmap for when remission is elusive
- (2018) Augustus John Rush et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion
- (2017) Steven J. Pennybaker et al. JOURNAL OF AFFECTIVE DISORDERS
- The Comparison of Effectiveness of Various Potential Predictors of Response to Treatment With SSRIs in Patients With Depressive Disorder
- (2017) Martin Bares et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- Depressive Symptom and Related Factors: A Cross-Sectional Study of Korean Female Workers Working at Traditional Markets
- (2017) Won Hwang et al. International Journal of Environmental Research and Public Health
- Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: A systematic review
- (2016) Vera De Carlo et al. PSYCHIATRY RESEARCH
- Inflammatory Biomarkers as Differential Predictors of Antidepressant Response
- (2015) Kenji Hashimoto INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Both body weight and BMI predicts improvement in symptom and functioning for patients with major depressive disorder
- (2014) Ching-Hua Lin et al. JOURNAL OF AFFECTIVE DISORDERS
- Do the dissociative side effects of ketamine mediate its antidepressant effects?
- (2014) David A. Luckenbaugh et al. JOURNAL OF AFFECTIVE DISORDERS
- Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
- (2014) Mark J. Niciu et al. JOURNAL OF CLINICAL PSYCHIATRY
- Treatment-resistant depression: therapeutic trends, challenges, and future directions
- (2012) Al-harbi Patient Preference and Adherence
- Clinical issues in considering vagus nerve stimulation for treatment-resistant depression
- (2009) A. John Rush et al. EXPERIMENTAL NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now